Science & Enterprise subscription

Follow us on Twitter

  • Many thanks @SciSeeker https://t.co/uQy4yl5pQb
    about 3 hours ago
  • New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
    about 4 days ago
  • Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
    about 4 days ago
  • New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
    about 4 days ago
  • A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
    about 5 days ago

Please share Science & Enterprise

Infographic – Where Vaccine Distrust is Greatest

Chart: mistrust in vaccines

Click on image for full-size view (Statista)

22 June 2019. The recent outbreak of measles in the U.S. and in other parts of the world is traced in large part to mistrust of vaccines. While much attention is focused on the current measles outbreak, distrust of vaccines apparently goes beyond this one disease. Our friends at Statista published a chart this week with data from a global Wellcome Trust survey showing where that distrust is greatest, our infographic for this weekend.

The survey asked 140,000 respondents in 140 countries if they believed vaccines were safe, and the highest percentages of those saying “not much” or “not at all” are found in Europe and Africa. About 1 in 3 people in France (33%) do not believe in the safety of vaccines, which Statista says may be related to a current controversy over a pandemic flu vaccine. About a quarter, 24 to 26 percent, of those in Gabon, Togo, and Russia also do not trust the safety of vaccines.

In seven other countries, mainly in Europe, but also Burkina Faso and Haiti, 20 to 22 percent of respondents express distrust in vaccine safety. In the U.S., that percentage is 11 percent.

More from Science & Enterprise:

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.